Summary
University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduate degree and undergraduate degree program and also provides research services in libraries, museums, film, music archives, art galleries, horizon-broadening, humanity-serving of California. UCLA operates through its departments including anthropology, archaeology, applied linguistics, architecture and urban design, bio-engineering, bio-medical research, dentistry and digital humanities. The university also conducts variety of programs for students in community operations. UCLA is headquartered in Los Angeles, California, the US.
University of California Los Angeles - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of California Los Angeles, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of California Los Angeles, Medical Devices Deals, 2010 to YTD 2016 9
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of California Los Angeles, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
InvVax Receives Rights to Vaccine Technology from University of California, Los Angeles 12
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 13
Trethera Enters into Research Agreement with University of California, Los Angeles 15
Bristol-Myers Squibb Enters into Research Agreement with UCLA 16
BioNano Genomics Enters into Research Agreement with University of California, Los Angeles 17
Zymeworks Enters into Research Agreement with University of California, Los Angeles 18
NanoSmart Pharma Enters Into Research Agreement With UCLA For Pediatric Cancer Drug Development 19
UCLA Medical Center Forms Joint Venture With First Affiliated Hospital Of Medical School 20
Prometheus Labs Enters Into Research Agreement With University Of California 21
Licensing Agreements 22
Klyss Biotech Receives Rights to Antibody from University of California, Los Angeles 22
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 23
Max Biopharma Enters Into License Agreement With UCLA And Johns Hopkins University For Small Molecule Technology 24
Diamyd Medical Expands Licensing Agreement with University Of California, Los Angeles 25
BioTime Enters Into Licensing Agreement With University of California, Los Angeles 26
Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 27
Fibrocell Science Enters Into Licensing Agreement With University of California 28
Asset Transactions 29
Royalty Pharma Acquires Royalty Rights of Xtandi from University of California, Los Angeles for USD1.14 Billion 29
University of California Los Angeles - Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
University of California Los Angeles, Pharmaceuticals & Healthcare, Key Facts 1
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of California Los Angeles, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of California Los Angeles, Deals By Therapy Area, 2010 to YTD 2016 8
University of California Los Angeles, Medical Devices Deals, 2010 to YTD 2016 9
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
InvVax Receives Rights to Vaccine Technology from University of California, Los Angeles 12
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 13
Trethera Enters into Research Agreement with University of California, Los Angeles 15
Bristol-Myers Squibb Enters into Research Agreement with UCLA 16
BioNano Genomics Enters into Research Agreement with University of California, Los Angeles 17
Zymeworks Enters into Research Agreement with University of California, Los Angeles 18
NanoSmart Pharma Enters Into Research Agreement With UCLA For Pediatric Cancer Drug Development 19
UCLA Medical Center Forms Joint Venture With First Affiliated Hospital Of Medical School 20
Prometheus Labs Enters Into Research Agreement With University Of California 21
Klyss Biotech Receives Rights to Antibody from University of California, Los Angeles 22
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 23
Max Biopharma Enters Into License Agreement With UCLA And Johns Hopkins University For Small Molecule Technology 24
Diamyd Medical Expands Licensing Agreement with University Of California, Los Angeles 25
BioTime Enters Into Licensing Agreement With University of California, Los Angeles 26
Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 27
Fibrocell Science Enters Into Licensing Agreement With University of California 28
Royalty Pharma Acquires Royalty Rights of Xtandi from University of California, Los Angeles for USD1.14 Billion 29
University of California Los Angeles, Key Competitors 31
University of California Los Angeles, Key Employees 32
University of California Los Angeles, Subsidiaries 33
List of Figures
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of California Los Angeles, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of California Los Angeles, Medical Devices Deals, 2010 to YTD 2016 9
